Connect public, paid and private patent data with Google Patents Public Datasets

Bestimmung von nukleären matrixproteinen in flüssigkeiten

Info

Publication number
DE69230890T2
DE69230890T2 DE1992630890 DE69230890T DE69230890T2 DE 69230890 T2 DE69230890 T2 DE 69230890T2 DE 1992630890 DE1992630890 DE 1992630890 DE 69230890 T DE69230890 T DE 69230890T DE 69230890 T2 DE69230890 T2 DE 69230890T2
Authority
DE
Grant status
Grant
Patent type
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE1992630890
Other languages
English (en)
Other versions
DE69230890D1 (de )
Inventor
Anne Beausang
P Lidgard
E Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matritech Inc
Original Assignee
Matritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/525Tumor necrosis factor [TNF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00Detection of programmed cell death, i.e. apoptosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
DE1992630890 1991-10-31 1992-10-29 Bestimmung von nukleären matrixproteinen in flüssigkeiten Expired - Lifetime DE69230890T2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US78580491 true 1991-10-31 1991-10-31
PCT/US1992/009220 WO1993009437A3 (en) 1991-10-31 1992-10-29 Nuclear matrix protein fluid assay

Publications (1)

Publication Number Publication Date
DE69230890T2 true DE69230890T2 (de) 2000-12-07

Family

ID=25136671

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1992630890 Expired - Lifetime DE69230890D1 (de) 1991-10-31 1992-10-29 Bestimmung von nukleären matrixproteinen in flüssigkeiten
DE1992630890 Expired - Lifetime DE69230890T2 (de) 1991-10-31 1992-10-29 Bestimmung von nukleären matrixproteinen in flüssigkeiten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE1992630890 Expired - Lifetime DE69230890D1 (de) 1991-10-31 1992-10-29 Bestimmung von nukleären matrixproteinen in flüssigkeiten

Country Status (7)

Country Link
US (8) US5840503A (de)
JP (1) JP3190042B2 (de)
CA (1) CA2122473C (de)
DE (2) DE69230890D1 (de)
EP (1) EP0642668B1 (de)
ES (1) ES2147555T3 (de)
WO (1) WO1993009437A3 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009437A3 (en) * 1991-10-31 1993-06-10 Matritech Inc Nuclear matrix protein fluid assay
DE69333377D1 (de) * 1992-06-22 2004-02-12 Matritech Inc Neuartige marker maligner zelltypen in der inneren nukleären matrix
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
WO1997016206A8 (en) * 1995-11-03 1999-08-05 Robert R Bahnson Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
US6280956B1 (en) 1995-11-03 2001-08-28 University Of Pittsburgh Antibodies to bladder cancer nuclear matrix proteins and their use
US5914238A (en) 1996-06-05 1999-06-22 Matritech, Inc. Materials and methods for detection of breast cancer
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US6232443B1 (en) * 1997-04-08 2001-05-15 University Of Pittsburgh Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
JP3517642B2 (ja) * 1998-03-18 2004-04-12 ロシュ ダイアグノスティックス ゲーエムベーハー アポトーシス産物の検出
US7229772B1 (en) 1998-03-18 2007-06-12 Roche Diagnostics Gmbh Detection of apoptotic products
DE60035499T2 (de) 1999-05-17 2008-03-20 Cytyc Corp., Marlborough Identifizierung von material aus dem milchkanal der brust
US6617432B1 (en) 1999-10-15 2003-09-09 University Of Pittsburgh Nuclear matrix proteins polynucleotide sequences encoding them and their use
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US7012335B2 (en) 2000-02-22 2006-03-14 Samsung Electronics Co., Ltd. Semiconductor device wiring and method of manufacturing the same
US7654227B1 (en) * 2001-12-20 2010-02-02 Pat Yananton Absorbent pad for entrapping small and large particles, retaining liquids and eliminating odors
US7080373B2 (en) * 2001-03-07 2006-07-18 Freescale Semiconductor, Inc. Method and device for creating and using pre-internalized program files
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
JP4274856B2 (ja) * 2003-06-19 2009-06-10 オリンパス株式会社 Dnaとdna結合タンパク質との反応を検出する方法
JP4425919B2 (ja) * 2003-09-23 2010-03-03 エヌエックスピー ビー ヴィNxp B.V. 適応フィルタ
US7649988B2 (en) 2004-06-15 2010-01-19 Acoustic Technologies, Inc. Comfort noise generator using modified Doblinger noise estimate
JP5073491B2 (ja) * 2004-07-19 2012-11-14 プロテインシンプル 分析対象物の検出のための方法
US7846676B2 (en) * 2004-07-19 2010-12-07 Cell Biosciences, Inc. Methods and devices for analyte detection
US7935479B2 (en) * 2004-07-19 2011-05-03 Cell Biosciences, Inc. Methods and devices for analyte detection
US8021611B2 (en) * 2005-04-09 2011-09-20 ProteinSimple Automated micro-volume assay system
CA2608750A1 (en) 2005-05-18 2006-11-23 Novartis Ag Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
US20070015166A1 (en) * 2005-07-14 2007-01-18 Nilsen Thor W Lateral flow methods and devices for detection of nucleic acid binding proteins
WO2007035864A3 (en) 2005-09-20 2007-11-22 Cell Biosciences Inc Electrophoresis standards, methods and kits
US20080017512A1 (en) * 2006-07-24 2008-01-24 Bordunov Andrei V Coatings for capillaries capable of capturing analytes
WO2008057605A3 (en) * 2006-11-10 2008-07-17 Mike Helms Nuclear protein extraction medium and method of use
US20090023156A1 (en) * 2007-07-20 2009-01-22 Voss Karl O Methods and reagents for quantifying analytes
JP2011206049A (ja) * 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
WO2013155634A1 (en) 2012-04-19 2013-10-24 Jiaqi Wu Dual wavelength isoelectric focusing for determining drug load in antibody drug conjugates
US9766206B2 (en) 2013-09-27 2017-09-19 ProteinSimple Apparatus, systems, and methods for capillary electrophoresis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4882268A (en) * 1985-12-24 1989-11-21 Massachusetts Institute Of Technology Method for determining tissue of origin and degree of malignancy of tumor cells
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US4861581A (en) * 1986-12-05 1989-08-29 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US4937185A (en) * 1987-07-31 1990-06-26 The Ohio State University Research Foundation Detection of circulating antibodies to a cancer marker protein
WO1989006697A1 (en) * 1988-01-19 1989-07-27 The University Of Sydney Detection of cell death
US5017474A (en) * 1988-02-12 1991-05-21 Eastman Kodak Company Wash solution, test kit and method for the determination of an immunological ligand
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
EP0527941B1 (de) * 1990-05-01 1996-09-18 Isis Pharmaceuticals, Inc. Identifikation von neuen medikamenten und reagenzien
WO1993009437A3 (en) * 1991-10-31 1993-06-10 Matritech Inc Nuclear matrix protein fluid assay
DE69333377D1 (de) * 1992-06-22 2004-02-12 Matritech Inc Neuartige marker maligner zelltypen in der inneren nukleären matrix

Also Published As

Publication number Publication date Type
US20060127941A1 (en) 2006-06-15 application
DE69230890D1 (de) 2000-05-11 grant
JP3190042B2 (ja) 2001-07-16 grant
CA2122473A1 (en) 1993-05-13 application
US5965376A (en) 1999-10-12 grant
WO1993009437A3 (en) 1993-06-10 application
US5989826A (en) 1999-11-23 grant
ES2147555T3 (es) 2000-09-16 grant
US20030096304A1 (en) 2003-05-22 application
US5840503A (en) 1998-11-24 grant
JPH07500671A (de) 1995-01-19 application
US6410247B1 (en) 2002-06-25 grant
CA2122473C (en) 2001-01-23 grant
EP0642668B1 (de) 2000-04-05 grant
US20050059026A1 (en) 2005-03-17 application
US6740494B2 (en) 2004-05-25 grant
EP0642668A1 (de) 1995-03-15 application
US6162608A (en) 2000-12-19 grant
WO1993009437A2 (en) 1993-05-13 application

Similar Documents

Publication Publication Date Title
DE3603755A1 (de) Bilderzeugungsgeraet mit (abbildungs-) bereichswahl- und erhaltungsfunktionen
FI892081A (fi) Kvadratuurivastaanotin
FI924651A (fi) Substituerade hydrokinonderivat
DE69329087T2 (de) Bestimmung von Batterietemperatur und -typ
DE69208458T2 (de) Transdermale perfusion von flüssigkeiten
DE3205747A1 (de) Reflexionshohlraumszintillationsdetektor und dafuer vorgesehenes einheitszellenelement
DE3891397T1 (de) Setz- und aufzuchtgeraet
DK0383453T3 (da) Reg protein
FI944280A0 (fi) Mingreenin vastaisia indolyylialkyyli-pyridinyyli- ja-pyrimidinyyli-piperatsiinien syklobuteenidionijohdannaisia
DK110389D0 (da) Hjoernesamling i stilladser
FI88603C (fi) Noedbroms
FI98875C (fi) Ohutkalvoelektroluminesenssilaite
FI88811C (fi) Ridaospritsroer
DK321389D0 (da) Hydrostatisk fortraengningsmaskine
FI890811A (fi) Painenuppusihtilajittelulaite
FI98874B (fi) Ohutkalvoelektroluminesenssilaite
FI892743A (fi) Luupuikko
FI893294A (fi) Paperinliimauskoostumuksia
FI931981A (fi) Hopmonterbart konstruktionssystem
FI896240A0 (fi) Lumenpidätin
FI882163A (fi) Timmerelement
FI893759A (fi) Kylmäprofiilikannatin
FI88742B (fi) Borrstaongselement
FI954856A0 (fi) 13-alkyyli-11beta-fenyyligonaanit
FI953471A0 (fi) Vaexhaemmande belaeggningskompositioner